The missing cause approach to unmeasured confounding in pharmacoepidemiology-Reference-Cited by-同舟云学术

The missing cause approach to unmeasured confounding in pharmacoepidemiology

Published:2016-01-14 Issue:7 Volume:35 Page:1001-1016
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Abrahamowicz Michal¹²^ORCID,Bjerre Lise M.³⁴⁵,Beauchamp Marie-Eve²^ORCID,LeLorier Jacques⁶⁷,Burne Rebecca¹

Affiliation:

1. Department of Epidemiology, Biostatistics, and Occupational Health; McGill University; Montreal QC Canada

2. Division of Clinical Epidemiology; McGill University Health Centre; Montreal QC Canada

3. Department of Family Medicine; University of Ottawa; Ottawa ON Canada

4. School of Epidemiology, Public Health, and Preventive Medicine; University of Ottawa; Ottawa ON Canada

5. Bruyère Research Institute; Ottawa ON Canada

6. Departments of Medicine and Pharmacology; University of Montreal; Montreal QC Canada

7. Pharmacoepidemiology and Pharmacoeconomics; University of Montreal Hospital Research Center; Montreal QC Canada

Funder

Canadian Institutes for Health Research

Natural Sciences and Engineering Research Council of Canada

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.6818/fullpdf

Reference53 articles.

1. Evaluating the safety of medicines, with particular reference to contraception;Skegg;Statistics in Medicine,2001

2. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis;Wolfe;The Journal of Rheumatology,2002

3. Drug evaluation after marketing;Slone;Annals of Internal Medicine,1979

4. Confounding by indication;Walker;Epidemiology,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Weight of Evidence, Quantitative Bias, and Bounding Methods Evaluate Robustness of Real-world Evidence for Regulator and Health Technology Assessment Decisions on Medical Interventions?;Clinical Therapeutics;2023-12

2. Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: A use case studying depression as a risk factor for Alzheimer’s disease;Journal of Biomedical Informatics;2023-06

3. Strategies to Address Current Challenges in Real-World Evidence Generation in Japan;Drugs - Real World Outcomes;2023-05-13

4. Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: a use case studying depression as a risk factor for Alzheimer's disease;2022-07-20

5. Evaluating Montréal’s harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis;BMJ Open;2021-10